Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
B Shariat-Madar1, D Kolte2, A Verlangieri2, Z Shariat-Madar21College of Literature, Science, and the Arts, University of Michigan, Ann Arbor MI, USA; 2School of Pharmacy, Department of Pharmacology, University of Mississippi, University, MS, USAAbstract: Recently, we serendipitously discovered that...
Enregistré dans:
Auteurs principaux: | B Shariat-Madar, D Kolte, A Verlangieri, et al |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c9f6b9dea2034e42bdf178ec962e2909 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment
par: Shariat-Madar Z, et autres
Publié: (2010) -
GABAergic system in the endocrine pancreas: a new target for diabetes treatment
par: Wan Y, et autres
Publié: (2015) -
Strategy to combat obesity and to promote physical activity in Arab countries
par: Abdulrahman O Musaiger, et autres
Publié: (2011) -
TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
par: Shitalkumar P Zambad, et autres
Publié: (2011) -
Past, present, and future: Critical analysis of use of gastric bands in obese patients
par: Brad Snyder, et autres
Publié: (2010)